Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Machine Learning Algorithms Utilizing Functional Respiratory Imaging May Predict COPD Exacerbations.

Carter BW.

Acad Radiol. 2019 Jun 19. pii: S1076-6332(19)30272-7. doi: 10.1016/j.acra.2019.05.008. [Epub ahead of print] No abstract available.

PMID:
31229356
2.

ACR Appropriateness Criteria® Noninvasive Clinical Staging of Primary Lung Cancer.

Expert Panel on Thoracic Imaging:, de Groot PM, Chung JH, Ackman JB, Berry MF, Carter BW, Colletti PM, Hobbs SB, McComb BL, Movsas B, Tong BC, Walker CM, Yom SS, Kanne JP.

J Am Coll Radiol. 2019 May;16(5S):S184-S195. doi: 10.1016/j.jacr.2019.02.008.

PMID:
31054745
3.

Thoracic Manifestations of Genitourinary Neoplasms and Treatment-related Complications.

Stowell JT, Betancourt-Cuellar SL, Carter BW, Wu CC, Walker CM.

J Thorac Imaging. 2019 May;34(3):W36-W48. doi: 10.1097/RTI.0000000000000382.

PMID:
31009398
4.

Recognizing Radiation Therapy-related Complications in the Chest.

Benveniste MF, Gomez D, Carter BW, Betancourt Cuellar SL, Shroff GS, Benveniste APA, Odisio EG, Marom EM.

Radiographics. 2019 Mar-Apr;39(2):344-366. doi: 10.1148/rg.2019180061.

PMID:
30844346
5.

Leukemic Involvement in the Thorax.

Shroff GS, Truong MT, Carter BW, Benveniste MF, Kanagal-Shamanna R, Rauch G, Viswanathan C, Boddu PC, Daver N, Wu CC.

Radiographics. 2019 Jan-Feb;39(1):44-61. doi: 10.1148/rg.2019180069.

PMID:
30620703
6.

Systematic Review of the Literature: Best Practices.

Gupta S, Rajiah P, Middlebrooks EH, Baruah D, Carter BW, Burton KR, Chatterjee AR, Miller MM.

Acad Radiol. 2018 Nov;25(11):1481-1490. doi: 10.1016/j.acra.2018.04.025. Epub 2018 Jul 31.

PMID:
30442379
7.

Primary Lung Tumors in Children: Radiologic-Pathologic Correlation From the Radiologic Pathology Archives.

Lichtenberger JP 3rd, Biko DM, Carter BW, Pavio MA, Huppmann AR, Chung EM.

Radiographics. 2018 Nov-Dec;38(7):2151-2172. doi: 10.1148/rg.2018180192.

PMID:
30422774
8.

Comparison of Abdominal Computed Tomographic Enhancement and Organ Lesion Depiction Between Weight-Based Scanner Software Contrast Dosing and a Fixed-Dose Protocol in a Tertiary Care Oncologic Center.

Jensen CT, Blair KJ, Wagner-Bartak NA, Vu LN, Carter BW, Sun J, Bathala TK, Gupta S.

J Comput Assist Tomogr. 2019 Jan/Feb;43(1):155-162. doi: 10.1097/RCT.0000000000000789.

PMID:
30211799
9.

Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma.

Kalaora S, Wolf Y, Feferman T, Barnea E, Greenstein E, Reshef D, Tirosh I, Reuben A, Patkar S, Levy R, Quinkhardt J, Omokoko T, Qutob N, Golani O, Zhang J, Mao X, Song X, Bernatchez C, Haymaker C, Forget MA, Creasy C, Greenberg P, Carter BW, Cooper ZA, Rosenberg SA, Lotem M, Sahin U, Shakhar G, Ruppin E, Wargo JA, Friedman N, Admon A, Samuels Y.

Cancer Discov. 2018 Nov;8(11):1366-1375. doi: 10.1158/2159-8290.CD-17-1418. Epub 2018 Sep 12.

10.

The epidemiology of lung cancer.

de Groot PM, Wu CC, Carter BW, Munden RF.

Transl Lung Cancer Res. 2018 Jun;7(3):220-233. doi: 10.21037/tlcr.2018.05.06. Review.

11.

CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade.

Chen L, Diao L, Yang Y, Yi X, Rodriguez BL, Li Y, Villalobos PA, Cascone T, Liu X, Tan L, Lorenzi PL, Huang A, Zhao Q, Peng D, Fradette JJ, Peng DH, Ungewiss C, Roybal J, Tong P, Oba J, Skoulidis F, Peng W, Carter BW, Gay CM, Fan Y, Class CA, Zhu J, Rodriguez-Canales J, Kawakami M, Byers LA, Woodman SE, Papadimitrakopoulou VA, Dmitrovsky E, Wang J, Ullrich SE, Wistuba II, Heymach JV, Qin FX, Gibbons DL.

Cancer Discov. 2018 Sep;8(9):1156-1175. doi: 10.1158/2159-8290.CD-17-1033. Epub 2018 Jul 16.

PMID:
30012853
12.

Managing Incidental Findings on Thoracic CT: Mediastinal and Cardiovascular Findings. A White Paper of the ACR Incidental Findings Committee.

Munden RF, Carter BW, Chiles C, MacMahon H, Black WC, Ko JP, McAdams HP, Rossi SE, Leung AN, Boiselle PM, Kent MS, Brown K, Dyer DS, Hartman TE, Goodman EM, Naidich DP, Kazerooni EA, Berland LL, Pandharipande PV.

J Am Coll Radiol. 2018 Aug;15(8):1087-1096. doi: 10.1016/j.jacr.2018.04.029. Epub 2018 Jun 22.

PMID:
29941240
13.

Immunotherapy in Lung Cancer and the Role of Imaging.

Carter BW.

Semin Ultrasound CT MR. 2018 Jun;39(3):314-321. doi: 10.1053/j.sult.2018.02.004. Epub 2018 Mar 6. Review.

PMID:
29807642
14.

Imaging on Lung Cancer and Treatment with Targeted Therapy.

Shroff GS, Benveniste MF, de Groot PM, Carter BW, Wu CC, Viswanathan C, Truong MT.

Semin Ultrasound CT MR. 2018 Jun;39(3):308-313. doi: 10.1053/j.sult.2018.02.003. Epub 2018 Mar 6. Review.

PMID:
29807641
15.

Imaging of Radiation Treatment of Lung Cancer.

Benveniste MF, Betancourt Cuellar SL, Gomez D, Shroff GS, Carter BW, Benveniste APA, Marom EM.

Semin Ultrasound CT MR. 2018 Jun;39(3):297-307. doi: 10.1053/j.sult.2018.02.002. Epub 2018 Mar 6. Review.

PMID:
29807640
16.

PET/CT Interpretative Pitfalls in Thoracic Malignancies.

Shroff GS, Sabloff BS, Truong MT, Carter BW, Viswanathan C.

Semin Ultrasound CT MR. 2018 Jun;39(3):282-288. doi: 10.1053/j.sult.2018.02.007. Epub 2018 Mar 8. Review.

PMID:
29807638
17.

Incidental Findings on Lung Cancer Screening: Significance and Management.

Tsai EB, Chiles C, Carter BW, Godoy MCB, Shroff GS, Munden RF, Truong MT, Wu CC.

Semin Ultrasound CT MR. 2018 Jun;39(3):273-281. doi: 10.1053/j.sult.2018.02.005. Epub 2018 Mar 1. Review.

PMID:
29807637
18.

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV.

Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.

PMID:
29773717
19.

Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.

Robichaux JP, Elamin YY, Tan Z, Carter BW, Zhang S, Liu S, Li S, Chen T, Poteete A, Estrada-Bernal A, Le AT, Truini A, Nilsson MB, Sun H, Roarty E, Goldberg SB, Brahmer JR, Altan M, Lu C, Papadimitrakopoulou V, Politi K, Doebele RC, Wong KK, Heymach JV.

Nat Med. 2018 May;24(5):638-646. doi: 10.1038/s41591-018-0007-9. Epub 2018 Apr 23.

20.

Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer.

Fang P, Musall BC, Son JB, Moreno AC, Hobbs BP, Carter BW, Fellman BM, Mawlawi O, Ma J, Lin SH.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):996-1001. doi: 10.1016/j.ijrobp.2018.02.029. Epub 2018 Mar 2.

PMID:
29685377
21.

Immunotherapy and the role of imaging.

Carter BW, Bhosale PR, Yang WT.

Cancer. 2018 Jul 15;124(14):2906-2922. doi: 10.1002/cncr.31349. Epub 2018 Apr 19. Review.

PMID:
29671876
22.

Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT.

Goense L, Ruurda JP, Carter BW, Fang P, Ho L, Meijer GJ, van Hillegersberg R, Hofstetter WL, Lin SH.

Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1742-1751. doi: 10.1007/s00259-018-4011-6. Epub 2018 Apr 16.

23.

Targeted Therapy and Immunotherapy in the Treatment of Non-Small Cell Lung Cancer.

Shroff GS, de Groot PM, Papadimitrakopoulou VA, Truong MT, Carter BW.

Radiol Clin North Am. 2018 May;56(3):485-495. doi: 10.1016/j.rcl.2018.01.012. Review.

PMID:
29622080
24.

Lung Cancer: Posttreatment Imaging: Radiation Therapy and Imaging Findings.

Benveniste MF, Welsh J, Viswanathan C, Shroff GS, Betancourt Cuellar SL, Carter BW, Marom EM.

Radiol Clin North Am. 2018 May;56(3):471-483. doi: 10.1016/j.rcl.2018.01.011. Review.

PMID:
29622079
25.

Staging Lung Cancer: Metastasis.

Shroff GS, Viswanathan C, Carter BW, Benveniste MF, Truong MT, Sabloff BS.

Radiol Clin North Am. 2018 May;56(3):411-418. doi: 10.1016/j.rcl.2018.01.009. Epub 2018 Mar 7. Review.

PMID:
29622076
26.

Staging Lung Cancer: Regional Lymph Node Classification.

El-Sherief AH, Lau CT, Carter BW, Wu CC.

Radiol Clin North Am. 2018 May;56(3):399-409. doi: 10.1016/j.rcl.2018.01.008. Review.

PMID:
29622075
27.

Missed Lung Cancer.

Hossain R, Wu CC, de Groot PM, Carter BW, Gilman MD, Abbott GF.

Radiol Clin North Am. 2018 May;56(3):365-375. doi: 10.1016/j.rcl.2018.01.004. Epub 2018 Mar 7. Review.

PMID:
29622072
28.

MR Imaging of Cardiac Masses.

Lichtenberger JP 3rd, Dulberger AR, Gonzales PE, Bueno J, Carter BW.

Top Magn Reson Imaging. 2018 Apr;27(2):103-111. doi: 10.1097/RMR.0000000000000166. Review.

PMID:
29613965
29.

MR Imaging of Thoracic Aortic Disease.

Lichtenberger JP 3rd, Franco DF, Kim JS, Carter BW.

Top Magn Reson Imaging. 2018 Apr;27(2):95-102. doi: 10.1097/RMR.0000000000000165. Review.

PMID:
29613964
30.

MR Imaging of Primary Chest Wall Neoplasms.

Bueno J, Lichtenberger JP 3rd, Rauch G, Carter BW.

Top Magn Reson Imaging. 2018 Apr;27(2):83-93. doi: 10.1097/RMR.0000000000000164. Review.

PMID:
29613963
31.

MR Imaging of Pleural Neoplasms.

Carter BW, Betancourt SL, Shroff GS, Lichtenberger JP 3rd.

Top Magn Reson Imaging. 2018 Apr;27(2):73-82. doi: 10.1097/RMR.0000000000000162. Review.

PMID:
29613962
32.

MR Imaging of Thymic Epithelial Neoplasms.

Carter BW, Lichtenberger JP 3rd, Benveniste MF.

Top Magn Reson Imaging. 2018 Apr;27(2):65-71. doi: 10.1097/RMR.0000000000000160. Review.

PMID:
29613961
33.

MR Imaging of Chest and Chest Wall Disease.

Carter BW.

Top Magn Reson Imaging. 2018 Apr;27(2):63-64. doi: 10.1097/RMR.0000000000000161. No abstract available.

PMID:
29613960
34.

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.

Goense L, van Rossum PSN, Xi M, Maru DM, Carter BW, Meijer GJ, Ho L, van Hillegersberg R, Hofstetter WL, Lin SH.

Ann Surg Oncol. 2018 Jun;25(6):1598-1607. doi: 10.1245/s10434-018-6435-4. Epub 2018 Mar 22.

35.

Pitfalls and Misinterpretations of Cardiac Findings on PET/CT Imaging: A Careful Look at the Heart in Oncology Patients.

Betancourt Cuellar SL, Palacio D, Benveniste MF, Carter BW, Gladish G.

Curr Probl Diagn Radiol. 2019 Mar - Apr;48(2):172-183. doi: 10.1067/j.cpradiol.2018.02.002. Epub 2018 Feb 6. Review.

PMID:
29549978
36.

Revisions to the TNM Staging of Lung Cancer: Rationale, Significance, and Clinical Application.

Carter BW, Lichtenberger JP 3rd, Benveniste MK, de Groot PM, Wu CC, Erasmus JJ, Truong MT.

Radiographics. 2018 Mar-Apr;38(2):374-391. doi: 10.1148/rg.2018170081. Review.

PMID:
29528831
37.

Imaging of Combat-Related Thoracic Trauma - Blunt Trauma and Blast Lung Injury.

Lichtenberger JP, Kim AM, Fisher D, Tatum PS, Neubauer B, Peterson PG, Carter BW.

Mil Med. 2018 Mar 1;183(3-4):e89-e96. doi: 10.1093/milmed/usx033.

PMID:
29514343
38.

Imaging of Combat-Related Thoracic Trauma - Review of Penetrating Trauma.

Lichtenberger JP, Kim AM, Fisher D, Tatum PS, Neubauer B, Peterson PG, Carter BW.

Mil Med. 2018 Mar 1;183(3-4):e81-e88. doi: 10.1093/milmed/usx034. Review.

PMID:
29514336
39.

Imaging in Congenital and Hereditary Abnormalities of the Interventricular Septum: Clinical Anatomy and Diagnostic Clues.

Kim AM, Hunter TA, McQuillan BF, Franco DF, Griffith TP, Carter BW, Lichtenberger JP 3rd.

J Thorac Imaging. 2018 May;33(3):147-155. doi: 10.1097/RTI.0000000000000326. Review.

PMID:
29489583
40.

Cystic mediastinal masses and the role of MRI.

Madan R, Ratanaprasatporn L, Ratanaprasatporn L, Carter BW, Ackman JB.

Clin Imaging. 2018 Jul - Aug;50:68-77. doi: 10.1016/j.clinimag.2017.12.011. Epub 2017 Dec 27. Review.

PMID:
29324329
41.

Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma.

Tsao AS, Lin H, Carter BW, Lee JJ, Rice D, Vaporcyan A, Swisher S, Mehran R, Heymach J, Nilsson M, Fan Y, Nunez M, Diao L, Wang J, Fujimoto J, Wistuba II, Hong WK.

J Thorac Oncol. 2018 Feb;13(2):246-257. doi: 10.1016/j.jtho.2017.10.033. Epub 2017 Dec 5.

42.

Screening for Lung Cancer: Lexicon for Communicating With Health Care Providers.

Carter BW, Lichtenberger JP 3rd, Wu CC, Munden RF.

AJR Am J Roentgenol. 2018 Mar;210(3):473-479. doi: 10.2214/AJR.17.18865. Epub 2017 Dec 20.

PMID:
29261349
43.

Imaging of Metastases in the Chest: Mechanisms of Spread and Potential Pitfalls.

Shroff GS, Benveniste MF, Carter BW, de Groot PM, Wu CC, Viswanathan C, Sabloff BS, Truong MT.

Semin Ultrasound CT MR. 2017 Dec;38(6):594-603. doi: 10.1053/j.sult.2017.07.007. Epub 2017 Aug 2.

PMID:
29179899
44.

Positron Emission Tomography/Computed Tomography in Esophageal Carcinoma: Applications and Limitations.

Betancourt Cuellar SL, Palacio DP, Benveniste MF, Carter BW, Hofstetter WL, Marom EM.

Semin Ultrasound CT MR. 2017 Dec;38(6):571-583. doi: 10.1053/j.sult.2017.07.008. Epub 2017 Aug 8.

PMID:
29179897
45.

Imaging of iatrogenic oesophageal injuries using optimized CT oesophageal leak protocol: pearls and pitfalls.

Madan R, Laur O, Crudup B, Peavy L, Carter BW.

Br J Radiol. 2018 Feb;91(1083):20170629. doi: 10.1259/bjr.20170629. Epub 2017 Dec 15. Review.

46.

18FDG-PET/CT is useful in the follow-up of surgically treated patients with oesophageal adenocarcinoma.

Betancourt Cuellar SL, Palacio DP, Wu CC, Carter BW, Correa AM, Hofstetter WL, Marom EM.

Br J Radiol. 2018 Feb;91(1082):20170341. doi: 10.1259/bjr.20170341. Epub 2017 Nov 28.

47.

Lung Cancer: Posttreatment Imaging: Radiation Therapy and Imaging Findings.

Benveniste MF, Gomez D, Viswanathan C, Shroff GS, Betancourt Cuellar SL, Carter BW, Marom EM.

J Thorac Imaging. 2017 Sep;32(5):288-299. doi: 10.1097/RTI.0000000000000293. Review.

PMID:
28832415
48.

Lung Cancer: Postoperative Imaging and Complications.

de Groot PM, Shroff GS, Carter BW, Godoy MCB, Plodkowski AJ, P Ko J, Munden RF.

J Thorac Imaging. 2017 Sep;32(5):276-287. doi: 10.1097/RTI.0000000000000292. Review.

PMID:
28832414
49.

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.

Reuben A, Spencer CN, Prieto PA, Gopalakrishnan V, Reddy SM, Miller JP, Mao X, De Macedo MP, Chen J, Song X, Jiang H, Chen PL, Beird HC, Garber HR, Roh W, Wani K, Chen E, Haymaker C, Forget MA, Little LD, Gumbs C, Thornton RL, Hudgens CW, Chen WS, Austin-Breneman J, Sloane RS, Nezi L, Cogdill AP, Bernatchez C, Roszik J, Hwu P, Woodman SE, Chin L, Tawbi H, Davies MA, Gershenwald JE, Amaria RN, Glitza IC, Diab A, Patel SP, Hu J, Lee JE, Grimm EA, Tetzlaff MT, Lazar AJ, Wistuba II, Clise-Dwyer K, Carter BW, Zhang J, Futreal PA, Sharma P, Allison JP, Cooper ZA, Wargo JA.

NPJ Genom Med. 2017;2. pii: 10. doi: 10.1038/s41525-017-0013-8. Epub 2017 Apr 7.

50.

Immunotherapy in Non-Small Cell Lung Cancer Treatment: Current Status and the Role of Imaging.

Carter BW, Halpenny DF, Ginsberg MS, Papadimitrakopoulou VA, de Groot PM.

J Thorac Imaging. 2017 Sep;32(5):300-312. doi: 10.1097/RTI.0000000000000291. Review.

PMID:
28786858

Supplemental Content

Loading ...
Support Center